Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Defactinib (INN, codenamed VS-6063) is an inhibitor of PTK2, also known as focal adhesion kinase (FAK), Pyk2, and MELK which was developed by Pfizer and licensed to Verastem Oncology as a potential treatment for solid tumors.
The analysis highlights Overview, Related Topics and Entities as prominent areas in the source structure around Defactinib.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around Defactinib shows recurring relationship patterns in the source. For example, Defactinib → Interactive image Another extracted example is Defactinib → 1073154-85-4. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
also vs-6063 inn inhibitor pyk2 melk pfizer mesothelioma nf2 codenamed ptk2 known focal adhesion kinase fak developed licensed verastem oncology
TTTA extracted 13 structured relationships around Defactinib. Examples in this analysis include Defactinib → 3D model (JSmol) → Interactive image and Defactinib → CAS Number → 1073154-85-4. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Defactinib | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Defactinib | CAS Number | 1073154-85-4 | 1.00 | infobox |
| Defactinib | ChEMBL | ChEMBL3137331 | 1.00 | infobox |
| Defactinib | ChemSpider | 32695161 | 1.00 | infobox |
| Defactinib | CompTox Dashboard (EPA) | DTXSID901025937 | 1.00 | infobox |
| Defactinib | DrugBank | DB12282 | 1.00 | infobox |
| Defactinib | Formula | C20H21F3N8O3S | 1.00 | infobox |
| Defactinib | KEGG | D10618 | 1.00 | infobox |
| Defactinib | Molar mass | 510.50 g·mol−1 | 1.00 | infobox |
| Defactinib | Other names | PF-04554878, VS-6063 | 1.00 | infobox |
| Defactinib | PDB ligand | 7KD (PDBe, RCSB PDB) | 1.00 | infobox |
| Defactinib | PubChem CID | 25117126 | 1.00 | infobox |
| Defactinib | UNII | 53O87HA2QU | 1.00 | infobox |
The concept neighborhoods around Defactinib bring nearby vocabulary together. In this analysis, examples include Vs-6063, Adhesion and Codenamed. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
Bridges highlight paths between different parts of the Defactinib map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Defactinib to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Overview, Related Topics & Entities, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Defactinib · EN edition · Analysis: TopicsToTalkAbout
